Using antifibrinolytics to tackle neuroinflammation  

作　　者：Stanimir Atsev Nikola Tomov 

机构地区：[1]Faculty of Medicine,Trakia University,Stara Zagora,Bulgaria [2]Institute of Anatomy,University of Bern,Bern,Switzerland

出　　处：《Neural Regeneration Research》2020年第12期2203-2206,共4页中国神经再生研究（英文版）

摘　　要：Plasmin is generally known as a promotor of inflammation.Recent advancement suggests that it has a complex role as immunity modulator.Pharmacological inhibition of plasmin production and activity has been proven to improve neurological outcomes in traumatic brain injury and subarachnoid hemorrhage,most probably by preventing re-bleeding.The immune-modulatory properties of antifibrinolytics,however,suggest that they probably have effects unrelated to fibrinolysis inhibition,which are currently not adequately harnessed.The present work aims to give an account of the existing data regarding antifibrinolytics as agents influencing neuroinflammation.Preclinical and clinical studies on the possible influence of antifibrinolytics on neuroinflammation are scarce.However,the emerging evidence suggests that inhibition of plasmin(ogen)activity can ameliorate neuroinflammation to some extent.This data demonstrate that plasmin(ogen)is not exclusively involved in fibrinolysis,but also has other substrates and can precipitate in inflammatory processes.Investigation on the role of plasmin as the factor for the development of neuroinflammation shows the significant potential of antifibrinolytics as pharmacotherapy of neuroinflammationm,which is worthy of further exploration.

关 键 词：antifibrionolytics FIBRIN fibrinogen NEUROINFLAMMATION PLASMIN PLASMINOGEN tranexamic acid 

分 类 号：R741.05[医药卫生—神经病学与精神病学]